Table 1.
Amikacin-Ribosome 50S | Amikacin-Ribosome 30S Body | Amikacin-Ribosome 30S Head | Tigecycline-Ribosome 50S | Tigecycline-Ribosome 30S Body | Tigecycline-Ribosome 30S Head | |
---|---|---|---|---|---|---|
Map resolution (Å) (FSC = 0.143) | 2.7 | 2.9 | 3.0 | 2.5 | 2.7 | 3.0 |
Map sharpening B factor (Å2) | −47.3 | −55.7 | −51.6 | −82.5 | −99.3 | −131.4 |
Model Composition | ||||||
Non-hydrogen atoms | 83,514 | 33,322 | 16,864 | 83,855 | 33,279 | 16,906 |
Protein residues | 3,069 | 1,496 | 852 | 3,112 | 1,496 | 852 |
Nucleic acid residues | 2,800 | 1,040 | 477 | 2,800 | 1,040 | 477 |
Metal ions | 161 | 59 | 24 | 163 | 56 | 24 |
Ligand | none | amikacin | none | tigecycline ×3 | none | tigecycline |
General Validation | ||||||
CCb (model to map fit) | 0.86 | 0.83 | 0.86 | 0.86 | 0.84 | 0.70 |
Clashscore | 4.84 | 7.09 | 5.25 | 5.86 | 9.42 | 15.11 |
Root-mean-square Deviations | ||||||
Bond lengths (Å) | 0.007 | 0.012 | 0.007 | 0.008 | 0.010 | 0.007 |
Bond angles (°) | 0.775 | 0.974 | 0.702 | 0.730 | 0.794 | 0.853 |
Protein Geometry Validation | ||||||
Rotamer outliers (%) | 7.08 | 11.02 | 7.15 | 5.70 | 8.22 | 11.24 |
Ramachandran outliers (%) | 0.03 | 0.20 | 0.00 | 0.07 | 0.00 | 0.24 |
Ramachandran favored (%) | 94.46 | 90.54 | 92.58 | 95.42 | 91.90 | 91.03 |
RNA Geometry Validationc | ||||||
Sugar pucker outliers (%) | 0.64 | 0.38 | 0.21 | 0.57 | 0.38 | 0.42 |
Backbone conformation outliers (%) | 17.14 | 20.48 | 17.19 | 15.89 | 19.71 | 22.85 |
Obtained from Phenix refinement log unless otherwise stated.
CC, correlation coefficient.
Obtained from MolProbity Web server.